• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耶和华见证人的医疗护理中的临床策略。

Clinical strategies in the medical care of Jehovah's Witnesses.

作者信息

Remmers Paul A, Speer Alice J

机构信息

Department of Internal Medicine, Division of General Medicine, University of Texas Medical Branch, Galveston, TX 77555-1167, USA.

出版信息

Am J Med. 2006 Dec;119(12):1013-8. doi: 10.1016/j.amjmed.2006.04.016.

DOI:10.1016/j.amjmed.2006.04.016
PMID:17145240
Abstract

Jehovah's Witnesses are primarily known to physicians for their refusal of blood transfusions. Conflict arises at times with the medical staff concerning how best to manage their care. This article will begin with a brief description of the beliefs of Jehovah's Witnesses and will then recommend specific clinical strategies highlighting newer potential therapies according to the principles of bloodless medicine. The scenarios of bleeding and acute and chronic anemia will be discussed in detail for the care of these patients refusing red blood cell transfusions. An update in the use of blood substitutes will be mentioned as well as the surgical advances used today that can minimize blood loss for all patients. The experience of organ transplantation in Jehovah's Witnesses will be detailed. Further resources for physicians with questions in the care of these patients will be listed. Stressed throughout the article will be the need for a team approach and good communication between physicians to successfully care for their patients who are Jehovah's Witnesses.

摘要

耶和华见证人主要因拒绝输血而为医生们所熟知。他们与医护人员有时会在如何以最佳方式管理其治疗护理方面产生冲突。本文将首先简要描述耶和华见证人的信仰,然后根据无血医学原则推荐具体的临床策略,重点介绍更新的潜在疗法。将详细讨论出血以及急慢性贫血的情况,以照顾这些拒绝红细胞输血的患者。还将提及血液替代品的使用进展以及当今用于尽量减少所有患者失血的手术进展。将详细介绍耶和华见证人进行器官移植的经验。还将列出为在照顾这些患者时遇到问题的医生提供的更多资源。本文通篇强调的是,需要采用团队协作方法,医生之间要进行良好沟通,才能成功照顾耶和华见证人的患者。

相似文献

1
Clinical strategies in the medical care of Jehovah's Witnesses.耶和华见证人的医疗护理中的临床策略。
Am J Med. 2006 Dec;119(12):1013-8. doi: 10.1016/j.amjmed.2006.04.016.
2
Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses.重组人促红细胞生成素治疗危重症耶和华见证会信徒
Pharmacotherapy. 2008 Nov;28(11):1383-90. doi: 10.1592/phco.28.11.1383.
3
Jehovah's witnesses, blood transfusions and transplantations.耶和华见证人、输血与移植
Transplant Proc. 2004 Apr;36(3):499-501. doi: 10.1016/j.transproceed.2004.02.013.
4
ENT surgery, blood and Jehovah's Witnesses.耳鼻喉科手术、血液与耶和华见证人。
J Laryngol Otol. 2007 May;121(5):409-14. doi: 10.1017/S0022215106003744. Epub 2006 Nov 24.
5
[Jehovah's Witnesses refusal of blood: religious, legal and ethical aspects and considerations for anesthetic management].[耶和华见证人的输血拒绝:宗教、法律和伦理方面以及麻醉管理的考量]
Rev Esp Anestesiol Reanim. 2006 Jan;53(1):31-41.
6
The contemporary approach to the care of Jehovah's witnesses.耶和华见证人的当代护理方法。
J Trauma. 2008 Jul;65(1):237-47. doi: 10.1097/TA.0b013e318176cc66.
7
[Major surgery on Jehovah's Witnesses].[对耶和华见证人的大手术]
Tidsskr Nor Laegeforen. 2006 Oct 19;126(20):2658-61.
8
Oncological management of pediatric cancer patients belonging to Jehovah's Witnesses: a two-institutional experience report.对属于耶和华见证人的小儿癌症患者的肿瘤学管理:一份双机构经验报告。
Onkologie. 2004 Apr;27(2):131-7. doi: 10.1159/000076901.
9
How to approach major surgery where patients refuse blood transfusion (including Jehovah's Witnesses).如何应对患者拒绝输血的重大手术(包括耶和华见证会信徒)。
Ann R Coll Surg Engl. 2005 Jan;87(1):3-14. doi: 10.1308/1478708051414.
10
Comparisons of cardiac surgery outcomes in Jehovah's versus Non-Jehovah's Witnesses.耶和华见证人与非耶和华见证人心脏手术结果的比较。
Am J Cardiol. 2006 Nov 1;98(9):1223-5. doi: 10.1016/j.amjcard.2006.05.055. Epub 2006 Sep 7.

引用本文的文献

1
Everyday Cardiac Surgery in Jehovah's Witnesses of Typically Advanced Age: Clinical Outcome and Matched Comparison.老年耶和华见证人的日常心脏手术:临床结果及匹配对照
J Clin Med. 2023 Aug 3;12(15):5110. doi: 10.3390/jcm12155110.
2
Operating on Jehovah's Witnesses: A Challenging Surgical Issue.对耶和华见证人实施手术:一个具有挑战性的外科问题。
J Relig Health. 2022 Jun;61(3):2447-2457. doi: 10.1007/s10943-020-01175-5. Epub 2021 Jan 8.
3
Does tourniquet use decrease blood loss following primary total knee arthroplasty in Jehovah's Witness patients?
在接受初次全膝关节置换术的耶和华见证会患者中,使用止血带是否会减少失血量?
Jt Dis Relat Surg. 2020;31(3):419-425. doi: 10.5606/ehc.2020.76244.
4
Treating a Patient with Your Hands Tied: Acute Chest Syndrome in a Jehovah's Witness.在束手束脚的情况下治疗患者:一名耶和华见证人的急性胸部综合征
Cureus. 2020 Apr 21;12(4):e7769. doi: 10.7759/cureus.7769.
5
Use of platelet and erythroid growth factors during induction chemotherapy for acute lymphoblastic leukaemia in a Jehovah's Witness.在一名耶和华见证会成员的急性淋巴细胞白血病诱导化疗期间使用血小板和红细胞生成因子。
BMJ Case Rep. 2018 Dec 7;11(1):e226497. doi: 10.1136/bcr-2018-226497.
6
Knowledge of bloodless medicine among nurses at the Medical/Surgical Directorate of Komfo Anokye Teaching Hospital, Ghana; a descriptive cross sectional study.加纳孔福阿诺凯教学医院内科/外科护理部护士对非输血医学的认知;一项描述性横断面研究。
BMC Res Notes. 2017 Dec 19;10(1):747. doi: 10.1186/s13104-017-3094-7.
7
Results of open heart surgery in Jehovah's Witness patients. Single centre experience.耶和华见证会患者的心脏直视手术结果。单中心经验。
Kardiochir Torakochirurgia Pol. 2017 Sep;14(3):164-169. doi: 10.5114/kitp.2017.70529. Epub 2017 Sep 30.
8
Optimization of oxygen delivery in a Jehovah's Witness with severe anaemia after postpartum haemorrhage.产后出血后严重贫血的耶和华见证人的氧输送优化
Obstet Med. 2012 Mar;5(1):39-41. doi: 10.1258/om.2011.110043. Epub 2011 Dec 14.
9
Recombinant Human Erythropoietin Therapy for a Jehovah's Witness Child With Severe Anemia due to Hemolytic-Uremic Syndrome.重组人促红细胞生成素治疗一名因溶血性尿毒症综合征导致严重贫血的耶和华见证会儿童。
Korean J Pediatr. 2016 Feb;59(2):100-3. doi: 10.3345/kjp.2016.59.2.100. Epub 2016 Feb 29.
10
Induction with azacytidine followed by allogeneic hematopoietic stem cell transplantation in a Jehovah's Witness with acute monocytic leukemia.一名患有急性单核细胞白血病的耶和华见证会信徒接受阿扎胞苷诱导治疗后进行异基因造血干细胞移植。
Clin Case Rep. 2015 May;3(5):287-90. doi: 10.1002/ccr3.212. Epub 2015 Feb 13.